SUMEI WU

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PLANTATION, FL NPI 1124772454

General Payments — all program years on this page

$971.84

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $909.37 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $897.8118
Education $11.561

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $518.128
Lilly USA, LLC $146.564
ABBVIE INC. $95.941
Boehringer Ingelheim Pharmaceuticals, Inc. $46.342
Novo Nordisk AS $44.492
Astellas Pharma US Inc $33.891
Phadia US Inc. $24.031

By program year

Program yearAmountRecords
2023 $62.471
2024 $909.3719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067587016 Phadia US Inc. $24.03 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100253220 Novo Nordisk Inc $24.59 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100310719 Novo Nordisk Inc $19.90 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104200281 AstraZeneca Pharmaceuticals LP $122.28 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104272207 AstraZeneca Pharmaceuticals LP $23.10 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104523010 AstraZeneca Pharmaceuticals LP $100.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104589936 AstraZeneca Pharmaceuticals LP $22.10 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105646118 AstraZeneca Pharmaceuticals LP $11.56 03/12/2024 Education Undisputed 01/23/2026 View at CMS
1105676501 AstraZeneca Pharmaceuticals LP $18.83 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105693385 AstraZeneca Pharmaceuticals LP $95.25 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105897182 AstraZeneca Pharmaceuticals LP $125.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108442969 ABBVIE INC. $95.94 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117883893 Boehringer Ingelheim Pharmaceuticals, Inc. $22.56 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117883895 Boehringer Ingelheim Pharmaceuticals, Inc. $23.78 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135916617 Lilly USA, LLC $15.40 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135947929 Lilly USA, LLC $99.82 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135956165 Lilly USA, LLC $15.02 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135967040 Lilly USA, LLC $16.32 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139512203 Astellas Pharma US Inc $33.89 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.